X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (34078) 34078
Newsletter (1771) 1771
Newspaper Article (541) 541
Book Chapter (238) 238
Magazine Article (106) 106
Dissertation (102) 102
Publication (32) 32
Book / eBook (29) 29
Conference Proceeding (29) 29
Web Resource (26) 26
Reference (17) 17
Government Document (14) 14
Trade Publication Article (7) 7
Streaming Video (6) 6
Book Review (3) 3
Paper (3) 3
Transcript (1) 1
Video Recording (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (24291) 24291
hematology (12128) 12128
chronic myeloid leukemia (11206) 11206
oncology (10951) 10951
male (9953) 9953
female (9433) 9433
chronic myeloid-leukemia (8604) 8604
chronic myelogenous leukemia (8049) 8049
middle aged (7872) 7872
adult (7732) 7732
cancer (6930) 6930
leukemia (6922) 6922
leukemia, myelogenous, chronic, bcr-abl positive - drug therapy (5434) 5434
aged (5400) 5400
research (4937) 4937
imatinib mesylate (4841) 4841
leukemia, myelogenous, chronic, bcr-abl positive - genetics (4555) 4555
imatinib (4175) 4175
animals (4049) 4049
care and treatment (3837) 3837
leukemia, myelogenous, chronic, bcr-abl positive - pathology (3677) 3677
antineoplastic agents - therapeutic use (3595) 3595
benzamides (3262) 3262
adolescent (3102) 3102
bcr-abl (2987) 2987
treatment outcome (2895) 2895
hemic and lymphatic diseases (2822) 2822
pyrimidines - therapeutic use (2786) 2786
apoptosis (2715) 2715
chronic lymphocytic-leukemia (2670) 2670
fusion proteins, bcr-abl - genetics (2660) 2660
transplantation (2656) 2656
prognosis (2554) 2554
acute myeloid-leukemia (2524) 2524
mutation (2456) 2456
genetic aspects (2426) 2426
cml (2366) 2366
acute lymphoblastic-leukemia (2353) 2353
piperazines - therapeutic use (2352) 2352
therapy (2340) 2340
analysis (2305) 2305
stem cells (2252) 2252
mice (2179) 2179
oncology, experimental (2144) 2144
leukemia, myelogenous, chronic, bcr-abl positive - therapy (2138) 2138
immunology (2097) 2097
aged, 80 and over (2042) 2042
health aspects (2040) 2040
protein kinase inhibitors - therapeutic use (2022) 2022
expression (1927) 1927
cell biology (1917) 1917
child (1875) 1875
dasatinib (1843) 1843
risk factors (1746) 1746
tyrosine (1746) 1746
antineoplastic agents - pharmacology (1739) 1739
pharmacology & pharmacy (1696) 1696
antineoplastic agents (1693) 1693
chemotherapy (1687) 1687
drug therapy (1679) 1679
young adult (1646) 1646
leukemia, myelogenous, chronic, bcr-abl positive - metabolism (1615) 1615
bone marrow (1604) 1604
philadelphia chromosome (1571) 1571
antimitotic agents (1550) 1550
myeloid leukemia (1542) 1542
biochemistry & molecular biology (1532) 1532
transplantation, homologous (1524) 1524
cells (1501) 1501
gene expression (1476) 1476
bone-marrow-transplantation (1466) 1466
medicine & public health (1452) 1452
survival (1451) 1451
kinases (1449) 1449
proteins (1449) 1449
hematology, oncology and palliative medicine (1445) 1445
diagnosis (1434) 1434
cell line, tumor (1431) 1431
medicine, research & experimental (1389) 1389
patients (1374) 1374
pyrimidines - pharmacology (1366) 1366
tyrosine kinase inhibitors (1360) 1360
retrospective studies (1335) 1335
tyrosine kinase (1331) 1331
hematopoietic stem cells (1324) 1324
leukemia, myelogenous, chronic, bcr-abl positive - diagnosis (1322) 1322
resistance (1316) 1316
tyrosine kinase inhibitor (1310) 1310
philadelphia-chromosome (1298) 1298
bone marrow transplantation (1284) 1284
chronic disease (1260) 1260
protein-tyrosine kinases - antagonists & inhibitors (1255) 1255
nilotinib (1250) 1250
k562 cells (1221) 1221
apoptosis - drug effects (1217) 1217
genetics & heredity (1216) 1216
blast crisis (1185) 1185
drug resistance, neoplasm (1184) 1184
hematopoietic stem cell transplantation (1169) 1169
signal transduction (1157) 1157
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Gerstein Science - Stacks (12) 12
Online Resources - Online (11) 11
Collection Dvlpm't (Acquisitions) - Vendor file (7) 7
Collection Dvlpm't (Acquisitions) - Closed Orders (2) 2
Sunnybrook Health Sciences Centre - Sunnybrook Stacks (2) 2
Credit Valley Hospital - Stacks (1) 1
Media Commons - Audio Visual (1) 1
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (35306) 35306
Chinese (416) 416
French (294) 294
Japanese (286) 286
Russian (280) 280
German (275) 275
Spanish (264) 264
Portuguese (147) 147
Polish (113) 113
Italian (64) 64
Czech (63) 63
Hungarian (44) 44
Turkish (36) 36
Korean (25) 25
Dutch (16) 16
Slovenian (12) 12
Danish (9) 9
Norwegian (9) 9
Slovak (9) 9
Ukrainian (7) 7
Croatian (6) 6
Persian (6) 6
Serbian (6) 6
Swedish (6) 6
Hebrew (5) 5
Romanian (4) 4
Finnish (3) 3
Arabic (2) 2
Bulgarian (2) 2
Nauru (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


The New England journal of medicine, ISSN 1533-4406, 2017, Volume 376, Issue 10, pp. 917 - 927
Journal Article
The New England journal of medicine, ISSN 1533-4406, 2010, Volume 362, Issue 24, pp. 2251 - 2259
The treatment of chronic myeloid leukemia (CML) achieved a great leap forward with the development of imatinib, a BCR-ABL kinase inhibitor... 
CHRONIC MYELOGENOUS LEUKEMIA | MEDICINE, GENERAL & INTERNAL | PHASE CML-CP | MOLECULAR RESPONSES | UP SUSTAINED SURVIVAL | 800 MG | HARMONIZING CURRENT METHODOLOGY | FOLLOW-UP | PATIENTS RECEIVING IMATINIB | PATIENTS PTS | BCR-ABL TRANSCRIPTS | Humans | Leukemia, Myeloid, Chronic-Phase - pathology | Middle Aged | Male | Antineoplastic Agents - therapeutic use | Antineoplastic Agents - administration & dosage | Blast Crisis - prevention & control | Protein Kinase Inhibitors - adverse effects | Young Adult | Antineoplastic Agents - adverse effects | Aged, 80 and over | Adult | Female | Pyrimidines - administration & dosage | Leukemia, Myeloid, Chronic-Phase - drug therapy | Kaplan-Meier Estimate | Piperazines - therapeutic use | Imatinib Mesylate | Piperazines - adverse effects | Disease Progression | Protein Kinase Inhibitors - administration & dosage | Protein Kinase Inhibitors - therapeutic use | Pyrimidines - therapeutic use | Adolescent | Fusion Proteins, bcr-abl - antagonists & inhibitors | Pyrimidines - adverse effects | Aged | Benzamides | Nilotinib | Antiviral agents | Safety and security measures | Chronic myeloid leukemia | Drug therapy | Comparative analysis | Clinical trials | Drug dosages | Medical treatment | bcr-abl | pathology | Leukemia | Chronic-Phase | Myeloid | Klinisk medicin | 80 and over | Pyrimidines | administration & dosage | Fusion Proteins | Blast Crisis | drug therapy | Piperazines | Antineoplastic Agents | prevention & control | antagonists & inhibitors | Clinical Medicine | Protein Kinase Inhibitors | adverse effects | therapeutic use
Journal Article
Nature genetics, ISSN 1546-1718, 2012, Volume 45, Issue 1, pp. 18 - 24
Journal Article